These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 2423888)
1. [Hormone treatment of prostate carcinoma: past achievements and current perspectives]. Debruyne FM Ned Tijdschr Geneeskd; 1986 Apr; 130(17):768-71. PubMed ID: 2423888 [No Abstract] [Full Text] [Related]
2. New forms and future perspectives in endocrine treatment of prostatic carcinoma. Jacobi GH; Wenderoth UK Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463 [No Abstract] [Full Text] [Related]
3. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer. Nicholson RI; Walker KJ; Davies P Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778 [No Abstract] [Full Text] [Related]
4. Hormonal treatment in prostate cancer. Zbranca E; Preda C Endocrinologie; 1991; 29(1-2):91-7. PubMed ID: 1803495 [TBL] [Abstract][Full Text] [Related]
5. Treating prostate cancer. Part V: androgen deprivation and chemotherapy. Harv Mens Health Watch; 1999 Dec; 4(5):5-8. PubMed ID: 10564905 [No Abstract] [Full Text] [Related]
6. [Cancer of the prostate: new hormone therapies]. Namer M; Boublil JL; Kather R; Cavaglione G Bull Cancer; 1986; 73(1):47-55. PubMed ID: 3779122 [TBL] [Abstract][Full Text] [Related]
8. [Hormone-therapy of carcinoma of the breast]. Villani C; Mazzon I Minerva Ginecol; 1981 Jan; 33(1):3-26. PubMed ID: 7017505 [No Abstract] [Full Text] [Related]
9. Physiologic basis for hormonal theapy in carcinoma of the prostate. Walsh PC Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206 [No Abstract] [Full Text] [Related]
14. Complete androgen blockade for the treatment of prostate cancer. Labrie F; Dupont A; Belanger A Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740 [No Abstract] [Full Text] [Related]
15. Prostate cancer. Guthrie TH; Watson P Am Fam Physician; 1987 Oct; 36(4):217-24. PubMed ID: 3314438 [TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of metastasizing prostate carcinoma with special reference to the bioavailability of fosfestrol after oral administration]. Oelschläger H; Rothley D; Dunzendorfer U Arzneimittelforschung; 1988 Oct; 38(10):1502-12. PubMed ID: 3058134 [TBL] [Abstract][Full Text] [Related]
17. [New hormonal treatments of metastatic prostatic cancer. Review of the literature]. Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364 [No Abstract] [Full Text] [Related]
18. Hormonal therapy in prostatic carcinoma. Resnick MI Urology; 1984 Nov; 24(5 Suppl):18-23. PubMed ID: 6388092 [TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy in the management of prostatic cancer. Greenberg E Clin Endocrinol Metab; 1980 Jul; 9(2):369-81. PubMed ID: 6994946 [No Abstract] [Full Text] [Related]
20. Carcinoma of the prostate: early endocrine therapy is best. Spirnak JP; Resnick MI Semin Urol; 1983 Nov; 1(4):269-79. PubMed ID: 6399613 [No Abstract] [Full Text] [Related] [Next] [New Search]